Logo image of AXLA

AXCELLA HEALTH INC (AXLA) Stock Analyst Ratings

NASDAQ:AXLA - Nasdaq - US05454B2043 - Common Stock - Currency: USD

4.58  -0.9 (-16.42%)

After market: 3.42 -1.16 (-25.33%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to AXLA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 15870.09. This target is 346408.54% above the current price.
AXLA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AXLA.
In the previous month the buy percentage consensus was at a similar level.
AXLA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

AXLA Historical Analyst RatingsAXLA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -53 -48 -43 -38 -33 -28 -23 -18 -13 -8 -3 5 10 15

Price Target & Forecast

Price Low Median Mean High 4.58860.0915,870.0915,870.0931,779.56 - 18,679.28% 346,408.54% 346,408.54% 693,776.90%

Related screens

AXLA Current Analyst RatingAXLA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-02-16 HC Wainwright & Co. Maintains Neutral
2022-12-16 SVB Leerink Downgrade Outperform -> Market Perform
2022-12-15 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-11-02 Chardan Capital Maintains Buy
2022-10-03 HC Wainwright & Co. Maintains Buy
2022-08-03 SVB Leerink Maintains Outperform
2022-08-03 HC Wainwright & Co. Maintains Buy
2022-05-09 Chardan Capital Maintains Buy
2021-11-16 Chardan Capital Maintains Buy
2021-10-12 Noble Capital Markets Initiate Outperform
2021-09-22 Goldman Sachs Downgrade Buy -> Neutral
2021-07-30 JP Morgan Downgrade Neutral -> Underweight
2021-07-06 HC Wainwright & Co. Initiate Buy
2021-06-03 Chardan Capital Maintains Buy